|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 96.53 CHF | +0.10% |
|
-1.21% | +8.71% |
| 11.07. | Novartis verliert Patentklage gegen MSN Pharmaceuticals wegen Entresto-Generikum | MT |
| 11.07. | Novartis unterliegt vor US-Gericht im Patentstreit um Entresto | AW |
Hauptkonkurrenten
| % | % 5 Tage | Veränderung - 1 Monat | Veränderung - 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 J. | Veränd. 5 J. | Veränd. 10 J. | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.10% | -1.21% | -0.75% | +8.67% | +8.71% | -3.63% | +19.02% | +18.32% | -3.47% | 237 Mrd. | ||
| +0.80% | +3.42% | -2.44% | +5.96% | +3.54% | -15.72% | +144.53% | +387.76% | +800.56% | 718 Mrd. | ||
| -0.05% | +1.00% | -0.18% | +1.59% | +8.44% | +4.63% | -10.74% | +6.02% | +57.17% | 377 Mrd. | ||
| -0.48% | +2.07% | +0.23% | +6.93% | +7.78% | +12.47% | +27.31% | +93.71% | +174.38% | 338 Mrd. | ||
| -0.44% | -1.76% | -11.25% | +3.85% | -29.18% | -54.58% | +5.61% | +104.02% | +121.86% | 308 Mrd. | ||
| -0.17% | +0.23% | -4.45% | +2.38% | +0.86% | +1.14% | -20.39% | -22.27% | -7.30% | 259 Mrd. | ||
| +0.22% | +3.22% | -1.34% | +3.82% | +1.96% | -11.82% | -3.94% | +18.64% | +145.72% | 222 Mrd. | ||
| +0.37% | +3.42% | +2.40% | +5.68% | -15.89% | -34.51% | -10.88% | +6.93% | +43.79% | 210 Mrd. | ||
| +0.60% | +1.39% | +0.61% | +1.06% | +13.96% | -10.22% | +20.95% | +17.36% | +86.44% | 160 Mrd. | ||
| -1.17% | +0.44% | +3.30% | +14.60% | -4.45% | -12.34% | -50.67% | -28.04% | -27.74% | 144 Mrd. | ||
| +2.23% | +0.28% | +1.92% | +5.25% | +21.35% | +60.22% | +81.35% | +45.21% | -4.49% | 139 Mrd. | ||
| +0.75% | +2.82% | +3.71% | -4.74% | +17.30% | -3.35% | +65.07% | +60.76% | +264.92% | 121 Mrd. | ||
| -0.16% | +0.04% | -2.93% | -9.02% | -11.07% | -9.81% | -16.81% | -11.01% | -14.41% | 119 Mrd. | ||
| +1.02% | +1.83% | -4.84% | -7.79% | -16.30% | +17.00% | -36.04% | -18.22% | -32.43% | 96.34 Mrd. | ||
| -0.04% | +0.67% | -4.17% | +5.76% | +5.72% | -4.97% | -33.76% | -31.00% | -17.63% | 77.51 Mrd. | ||
| -0.51% | -0.77% | -8.21% | +3.18% | -2.14% | +12.95% | +84.91% | +26.27% | +350.59% | 76.79 Mrd. | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66 Mrd. | ||
| +0.54% | +8.66% | +6.16% | +17.07% | +24.64% | +38.62% | +48.48% | -30.25% | +303.10% | 53.34 Mrd. | ||
| +1.93% | +1.18% | +2.51% | +6.85% | +6.31% | +4.83% | +11.43% | +19.39% | -28.46% | 46.68 Mrd. | ||
| -0.14% | -1.00% | -6.01% | -2.91% | -2.62% | +10.53% | - | - | - | 44.37 Mrd. | ||
| Durchschnitt | +0.25% | +1.07% | -1.36% | +3.59% | +2.05% | +0.08% | +18.08% | +36.87% | +122.92% | 190.62 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.20% | +1.39% | -1.77% | +4.14% | +1.15% | -6.44% | +33.34% | +96.29% | +218.21% |
- Börse
- Aktien
- 904278 Aktie
- Sektor Novartis AG
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben